درباره این اپیزود
Inside the Qatar Genome Programme. The 2022 Phase One Mbarek paper that found 88 million variants in 6,047 Qataris, with 24 million novel. The 2024 Elfatih follow-up showing 3.5% of Qataris carry ACMG-actionable variants. The Q-Chip and the new pan-Arab array. And how the 96 percent Qatar share of Arab GWAS connects to the global equity question.
انگلیسی
ایالات متحده آمریکا
رونوشت 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
جستجوی اپیزودهای گذشته
اپیزودهای قبلی Personal Genomics Zone را جستجو کن.
قسمت های دیگر در این پادکست
A live webinar where AI agents do real genomics work end to end. After a short framing on why trust is the new bottleneck in agentic genomics, Veniamin Fishman and the Genomic Intelligence team run live: reading promoters, splicing, expression and enhancers straight from DNA, blind gene-finding on …
Can an LLM resist a motivated investor pushing a fraudulent pitch? Powdthavee's preregistered study across seven leading models and twelve scenarios finds they outperform humans at fraud detection, yet soften warnings when users arrive already convinced. Ellawela tracks LLM agents through repeated …
Manuel Corpas's opening talk for the Londonomics RNA Ideathon at the Francis Crick Institute, recorded 14 July 2026. The argument: the future of transcriptomics is not a smarter model, it is a trusted operating layer. Skills that carry a versioned context contract, fail safely, and keep a chain of …
Manuel narrates his UK DRI seminar at Imperial College London (29 April 2026): how agentic genomics shifts the bottleneck from pipeline construction to validation. An empirical benchmark of 8 frontier LLMs across 1,728 evaluations on the ClawBio pharmgx-reporter skill: 92.4% mean phenotype accuracy…
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به Manuel Corpas است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
